Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-17-011402
Filing Date
2017-12-07
Accepted
2017-12-07 16:56:13
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-1/A vtgns1am12017.htm S-1/A 4802705
2 FORM OF UNDERWRITING AGREEMENT ex1-1.htm EX-1.1 220070
3 FORM OF WARRANT ex4-1.htm EX-4.1 147228
4 OPINION ON LEGALITY ex5-1.htm EX-5.1 14070
5 CONSENTS OF EXPERTS AND COUNSEL ex23-2.htm EX-23.2 4387
6 IMAGE dlg.jpg GRAPHIC 15217
7 IMAGE vtgn.jpg GRAPHIC 6851
  Complete submission text file 0001654954-17-011402.txt   5220178
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: S-1/A | Act: 33 | File No.: 333-221009 | Film No.: 171245340
SIC: 2834 Pharmaceutical Preparations